Human norovirus detection and production, quantification, and storage of virus-like particles

Current Protocols in Microbiology

Volumn , Issue SUPPL.31, 2013, Pages

  Debbink, Kari ^a   Costantini, Veronica ^b   Swanstrom, Jesica ^a   Agnihothram, Sudhakar ^a   Vinjé, Jan ^b   Baric, Ralph ^a   Lindesmith, Lisa ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Norovirus; Venezuelan equine encephalitis virus; Virus replicon particle; Virus like particle; Virus like particle purification

Indexed keywords

COMPLEMENTARY DNA; PLASMID VECTOR;

ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; DNA PURIFICATION; FECES ANALYSIS; GENE INSERTION; IMMUNOCOMPETENT CELL; MOLECULAR CLONING; NONHUMAN; NOROVIRUS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS; VIRUS CAPSID; VIRUS DETECTION; VIRUS GENE; VIRUS LIKE AGENT; VIRUS PURIFICATION; VIRUS REPLICATION; ANIMAL; FECES; GENE VECTOR; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; PRESERVATION; VIROLOGY; VIRUS REPLICON PARTICLE; VIRUS-LIKE PARTICLE; VIRUS-LIKE PARTICLE PURIFICATION;

NOROVIRUS; VENEZUELAN EQUINE ENCEPHALITIS VIRUS; VIRUS REPLICON PARTICLE; VIRUS-LIKE PARTICLE; VIRUS-LIKE PARTICLE PURIFICATION;

ANIMALS; ENCEPHALITIS VIRUS, VENEZUELAN EQUINE; FECES; GENETIC VECTORS; HUMANS; NOROVIRUS; PRESERVATION, BIOLOGICAL; VIROLOGY;

EID: 84891589958     PISSN: 19348525     EISSN: 19348533     Source Type: Journal    
DOI: 10.1002/9780471729259.mc15k01s31     Document Type: Article

References (34)

1. Anonymous. 2011. Updated norovirus outbreak management and disease prevention guidelines. MMWR Recomm. Rep. 60:1-18.
2. Ausubel, F.M. Brent, R. Kingston, R.E., Moore, D.D., Seidman, J.G., Smith, J.A., and Struhl, K (eds.). 2013. Current Protocols in Molecular Biology. John Wiley & Sons, Hoboken, N.J.
3. Baric, R.S., Yount, B., Lindesmith, L., Harrington, P.R., Greene, S.R., Tseng, F.C., Davis, N., Johnston, R.E., Klapper, D.G., and Moe, C.L. 2002. Expression and self-assembly of norwalk virus capsid protein from venezuelan equine encephalitis virus replicons. J. Virol. 76:3023-3030.
4. Bok, K., Parra, G.I., Mitra, T., Abente, E., Shaver, C.K., Boon, D., Engle, R., Yu, C., Kapikian, A.Z., Sosnovtsev, S.V., Purcell, R.H., and Green, K.Y. 2011. Chimpanzees as an animal model for human norovirus infection and vaccine development. Proc.Natl. Acad. Sci.U.S.A. 108:325-330.
5. Cheetham, S., Souza, M., Meulia, T., Grimes, S., Han, M.G., and Saif, L.J. 2006. Pathogenesis of a genogroup II human norovirus in gnotobiotic pigs. J. Virol. 80:10372-10381.
6. Donaldson, E.F., Lindesmith, L.C., Lobue, A.D., and Baric, R.S. 2010. Viral shape-shifting: Norovirus evasion of the human immune system. Nat. Rev. Microbiol. 8:231-241.
7. Duizer, E., Schwab, K.J., Neill, F.H., Atmar, R.L., Koopmans, M.P., and Estes, M.K. 2004. Laboratory efforts to cultivate noroviruses. J. Gen. Virol. 85:79-87.
8. Harris, J.P., Edmunds, W.J., Pebody, R., Brown, D.W., and Lopman, B.A. 2008. Deaths from norovirus among the elderly, England and Wales. Emerg. Infect. Dis. 14:1546-1552.
9. Hart, M.K., Caswell-Stephan, K., Bakken, R., Tammariello, R., Pratt,W.,Davis,N., Johnston, R.E., Smith, J., and Steele, K. 2000. Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate. Vaccine 18:3067-3075.
10. Herbst-Kralovetz, M.M., Radtke, A.L., Lay, M.K., Hjelm, B.E., Bolick, A.N., Sarker, S.S., Atmar, R.L.,Kingsley, D.H.,Arntzen,C.J., Estes, M.K., and Nickerson, C.A. 2013. Lack of norovirus replication and histo-blood group antigen expression in 3-dimensional intestinal epithelial cells. Emerg. Infect. Dis. 19:431-438.
11. Huhti, L.,Blazevic,V.,Nurminen, K.,Koho, T.,Hytonen, V.P., and Vesikari, T. 2010. A comparison of methods for purification and concentration of norovirus GII-4 capsid virus-like particles. Arch. Virol. 155:1855-1858.
12. Jiang, X.,Wang, M.,Graham, D.Y., and Estes, M.K. 1992. Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J. Virol. 66:6527-6532.
13. Jiang, X., Matson, D.O., Cubitt, W.D., and Estes, M.K. 1996. Genetic and antigenic diversity of human caliciviruses (HuCVs) using RT-PCR and new EIAs. Arch. Virol. Suppl. 12:251-262.
14. Jung, K., Wang, Q., Kim, Y., Scheuer, K., Zhang, Z., Shen, Q., Chang, K.O., and Saif, L.J. 2012. The effects of simvastatin or interferon-alpha on infectivity of human norovirus using a gnotobiotic pig model for the study of antivirals. PLoS One 7:e41619.
15. Kapikian, A.Z., Wyatt, R.G., Dolin, R., Thornhill, T.S., Kalica, A.R., and Chanock, R.M. 1972. Visualization by immune electron microscopy of a 27-nm particle associated with acute infectious nonbacterial gastroenteritis. J. Virol. 10:1075-1081.
16. Koopmans, M., Vinje, J., de Wit, M., Leenen, I., van der Poel, W., and van Duynhoven, Y. 2000. Molecular epidemiology of human enteric caliciviruses in The Netherlands. J. Infect. Dis. 181:S262-S269.
17. Lay, M.K., Atmar, R.L., Guix, S., Bharadwaj, U., He, H., Neill, F.H., Sastry, K.J., Yao, Q., and Estes, M.K. 2010. Norwalk virus does not replicate in human macrophages or dendritic cells derived from the peripheral blood of susceptible humans. Virology 406:1-11.
18. Lindesmith, L., Moe, C., Marionneau, S., Ruvoen, N., Jiang, X., Lindblad, L., Stewart, P., LePendu, J., and Baric, R. 2003. Human susceptibility and resistance to Norwalk virus infection. Nat. Med. 9:548-553.
19. Lindesmith, L.C., Donaldson, E.F., and Baric, R.S. 2011. Norovirus GII.4 strain antigenic variation. J. Virol. 85:231-242.
20. Ma, Y. and Li, J. 2011. Vesicular stomatitis virus as a vector to deliver virus-like particles of human norovirus: A new vaccine candidate against an important noncultivable virus. J. Virol. 85:2942-2952.
21. Mason, H.S., Ball, J.M., Shi, J.J., Jiang, X., Estes, M.K., and Arntzen, C.J. 1996. Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. Proc. Natl. Acad. Sci. U.S.A. 93:5335-5340.
22. Prasad, B.V., Hardy, M.E., Dokland, T., Bella, J., Rossmann, M.G., and Estes, M.K. 1999. X-ray crystallographic structure of the Norwalk virus capsid. Science 286:287-290.
23. Pratt,W.D., Davis, N.L., Johnston, R.E., and Smith, J.F. 2003. Genetically engineered, live attenuated vaccines for Venezuelan equine encephalitis: Testing in animal models. Vaccine 21:3854-3862.
24. Pushko, P., Parker, M., Ludwig, G.V., Davis, N.L., Johnston, R.E., and Smith, J.F. 1997. Repliconhelper systems from attenuated Venezuelan equine encephalitis virus: Expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo. Virology 239:389-401.
25. Reed, D.S., Lind, C.M., Lackemeyer, M.G., Sullivan, L.J., Pratt, W.D., and Parker, M.D. 2005. Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus. Vaccine 23:3139-3147.
26. Schorn, R., Hohne, M., Meerbach, A., Bossart, W., Wuthrich, R.P., Schreier, E., Muller, N.J., and Fehr, T. 2010. Chronic norovirus infection after kidney transplantation: Molecular evidence for immune-driven viral evolution. Clin. Infect. Dis. 51:307-314.
27. Schultz, A.C., Vega, E., Dalsgaard, A., Christensen, L.S., Norrung, B.,Hoorfar, J., and Vinje, J. 2011. Development and evaluation of novel one-step TaqMan realtime RT-PCR assays for the detection and direct genotyping of genogroup I and II noroviruses. J. Clin. Virol. 50:230-234.
28. Siebenga, J.J., Vennema, H., Zheng, D.P., Vinje, J., Lee, B.E., Pang, X.L., Ho, E.C., Lim, W., Choudekar, A., Broor, S., Halperin, T., Rasool, N.B., Hewitt, J., Greening, G.E., Jin, M., Duan, Z.J., Lucero, Y., O'Ryan, M., Hoehne, M., Schreier, E., Ratcliff, R.M.,White, P.A., Iritani, N., Reuter, G., and Koopmans, M. 2009. Norovirus illness is a global problem: Emergence and spread of norovirus GII.4 variants, 2001-2007. J. Infect. Dis. 200:802-812.
29. Souza, M., Cheetham, S.M., Azevedo, M.S., Costantini, V., and Saif, L.J. 2007. Cytokine and antibody responses in gnotobiotic pigs after in-fection with human norovirus genogroup II.4 (HS66 strain). J. Virol. 81:9183-9192.
30. Tan, M., Zhong, W., Song, D., Thornton, S., and Jiang, X. 2004. E. coli-expressed recombinant norovirus capsid proteins maintain authentic antigenicity and receptor binding capability. J. Med. Virol. 74:641-649.
31. Vega, E., Barclay, L., Gregoricus, N.,Williams, K., Lee, D., and Vinje, J. 2011. Novel surveillance network for norovirus gastroenteritis outbreaks, United States. Emerg. Infect. Dis. 17:1389-1395.
32. Vinje, J., Green, J., Lewis, D.C., Gallimore, C.I., Brown, D.W., and Koopmans, M.P. 2000. Genetic polymorphism across regions of the three open reading frames of "Norwalk-like viruses." Arch. Virol. 145:223-241.
33. Voytas, D. 2000. Agarose gel electrophoresis. Curr. Protoc. Mol. Biol. 51:10.4.1-10.4.8.
34. Wobus, C.E., Karst, S.M., Thackray, L.B., Chang, K.O., Sosnovtsev, S.V., Belliot, G., Krug, A., Mackenzie, J.M., Green, K.Y., and Virgin, H.W. 2004. Replication of Norovirus in cell culture reveals a tropism for dendritic cells and macrophages. PLoS Biol. 2:e432.